This kind of confirms what I suspected already a few months ago when I openend a position in ADIAL. The clinical results where clear but the investors often only look at the overall result. And that overall result is what all the pseudo news channels write about.
But I keep saying that the heavy drinkers group is MUCH larger then the very heavy drinkers. Splitting this up, given we are dealing with an unmet need, is the way to go.
Market Data 
Markets 
AI
